Loading
MI
Mydecine Innovations Group Inc. Stock: price and insider trades · Canada
Mydecine Innovations Group Inc.: what insiders have been doing
Every trade that managers of Mydecine Innovations Group Inc. disclose to SEDI is tracked on this page. Between 21 October 2025 and 21 October 2026, 1 insider published 73 filings.
Purchases and sales both appear in the filings: 1 purchase (1 insider, €381k) and 65 sales (1 insider, €268k). Taken together, the purchases exceed the sales by €113k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Biggest ticket of the year: €381k, bought by Van Empel, Ray and made public on 23 December 2025. The buyers include 1 major shareholder.
For context, the typical company on the same exchange (median of 2,475 companies) published 12 filings over the same period, against 73 filings here. Since 2021, the database holds 4 purchases and 69 sales by insiders of the company.
The clock since the last published purchase (23 December 2025) now reads 302 days. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Insider Decl.
102
Thresholds
n/a
Buy Volume
€403,899
4 ops. · all time
Sell Volume
€1M
69 ops. · all time
Financial data
· cache
Last declaration on 23 December 2025
Declarations102 total
1 sharesCommon SharesTSXSEDI:4627546
1 sharesCommon SharesTSXSEDI:4627540
Common SharesTSXSEDI:4627541
1,505,879 sharesCommon SharesTSXSEDI:4627544
30,731 shares@ CA$0.005Common SharesTSXSEDI:4627545
14,125,465 sharesCommon SharesTSXSEDI:4627467
863,000 shares@ CA$0.58Common SharesTSXSEDI:4627470
Canonical exit: 13 Dec 2022 (T+90)
4,500 shares@ CA$0.79Common SharesTSXSEDI:4627471
6,000 shares@ CA$0.80Common SharesTSXSEDI:4627472
8,500 shares@ CA$0.79Common SharesTSXSEDI:4627474
9,000 shares@ CA$0.80Common SharesTSXSEDI:4627475
12,500 shares@ CA$0.77Common SharesTSXSEDI:4627477
11,500 shares@ CA$0.80Common SharesTSXSEDI:4627479
5,500 shares@ CA$0.80Common SharesTSXSEDI:4627480
11,250 shares@ CA$0.80Common SharesTSXSEDI:4627539
7,250 shares@ CA$0.82Common SharesTSXSEDI:4627481
10,500 shares@ CA$0.78Common SharesTSXSEDI:4627483
11,250 shares@ CA$0.80Common SharesTSXSEDI:4627484
4,500 shares@ CA$0.80Common SharesTSXSEDI:4627486
5,000 shares@ CA$0.78Common SharesTSXSEDI:4627487
7,000 shares@ CA$0.74Common SharesTSXSEDI:4627491
8,250 shares@ CA$0.76Common SharesTSXSEDI:4627488
25,000 shares@ CA$0.70Common SharesTSXSEDI:4627490
8,500 shares@ CA$0.72Common SharesTSXSEDI:4627492
9,000 shares@ CA$0.72Common SharesTSXSEDI:4627494
25 of 102 declarations
About Mydecine Innovations Group Inc.
Mydecine Innovations Group Inc. is a company focused on developing psychedelic treatments for mental health disorders. It is listed on the Toronto Stock Exchange under the ticker MYCO.
